ID 4042 -
Liściokwiat garbnikowy
PL: Liściokwiat garbnikowy
EN: Emblica officinalis (common name : Amla)
Pdf: various food(s)/food constituent(s) not supported by pertinent human data
1. Charakterystyka żywności / składnika
The food that is the subject of the health claims is “Emblica officinalis fruit rind”.
Emblica officinalis Gaertn. (synonym of the species Phyllanthus emblica L., also know as Indian gooseberry) is a tree of the Phyllanthaceae family (genus Phyllanthus) and it is known for its edible, round, light green fruits of the same name. The proposed conditions of use refer to powder and aqueous extract (ID 4041, 4042) and to raw fruit and raw fruit extract (ID 4041). The Panel notes that no information on the composition or manufacturing process of the powder and aqueous extract, or of the raw fruit extract, has been provided. However, the Panel notes that, from the references provided (Jacob et al., 1988), the raw fruit of Emblica officinalis Gaertn. can be characterised for its content of ascorbic acid, pectins, tannins and fibre in relation to the claimed effects.
The Panel considers that the food, the raw fruit of Emblica officinalis Gaertn., which is the subject of the health claims, is sufficiently characterised in relation to the claimed effects.
2.2. Ochrona DNA, białek i lipidów przed uszkodzeniem oksydacyjnym (ID 4042)
The claimed effect is “antioxidant, immunity”. The Panel assumes that the target population is the general population.
In the context of the proposed wordings, the Panel assumes that the claimed effect refers to the protection of DNA, proteins and lipids from oxidative damage.
The Panel considers that claims made on the antioxidant capacity/content of foods based on their capability of scavenging free radicals in vitro refer to a property of the food/food constituent measured in model systems, and that the information provided does not establish that this exerts a beneficial physiological effect in humans as required by Regulation (EC) No 1924/2006.
Reactive oxygen species (ROS) including several kinds of radicals are generated in biochemical processes (e.g. respiratory chain) and as a consequence of exposure to exogenous factors (e.g. radiation, pollutants). These reactive intermediates damage molecules such as DNA, proteins and lipids if they are not intercepted by the antioxidant network which includes free radical scavengers such as antioxidant nutrients.
The Panel considers that protection of DNA, proteins and lipids from oxidative damage may be a beneficial physiological effect.
3.2. Ochrona DNA, białek i lipidów przed uszkodzeniem oksydacyjnym (ID 4042)
Among the references provided for the scientific substantiation of the claim were two references which were not accessible to the Panel even after every reasonable effort had been made to retrieve them, and a number of textbooks which did not include any original data for the scientific
substantiation of the claim. The Panel considers that no conclusions can be drawn from these references for the scientific substantiation of the claim.
The Panel notes that no human studies which addressed outcomes related to the claimed effect have been provided. The Panel considers that evidence provided in animal and in vitro studies is not sufficient to predict the occurrence of an effect of Emblica officinalis Gaertn. consumption on protection of DNA, proteins and lipids from oxidative damage in vivo in humans.
The Panel concludes that a cause and effect relationship has not been established between the consumption of the raw fruit of Emblica officinalis Gaertn. and protection of DNA, proteins and lipids from oxidative damage.
Warunki i możliwe ograniczenia stosowania oświadczenia
Powder 3-0.2 g/day; aqueous extra 1.5-0.1 g/day
All over 2 years old: 2-4 years ¼ adult dose, 4-10 years half adult dose
